A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer

A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer

The fourth common reason of death among patients is gastric cancer (GC) and it is a dominant tumor type in Ease Asia. One of the problems in GC therapy is chemoresistance. Cisplatin (CP) is a platinum compound that causes DNA damage in reducing tumor progression and viability of cancer cells. Howeve...

Full description

Bibliographic Details
Main Authors: Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, Rahman S. Zabibah, Qakhramon Shomurodov, Mostafai N. Kadheim, Fahad Alsaikhan, Pushpamala Ramaiah, Lathamangeswari Chinnasamy, Saeed Samarghandian
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cisplatin
Molecular pathways
Chemoresistance
Gastric cancer
Pharmacological compounds
Nanoplatforms
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223011289

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223011289

Similar Items